Detection and genotyping of human papillomavirus in urine samples from unvaccinated male and female adolescents in Italy

PLoS ONE

Volumn 8, Issue 11, 2013, Pages

  Bianchi, Silvia ^a   Frati, Elena Rosanna ^a   Panatto, Donatella ^b   Martinelli, Marianna ^a   Amicizia, Daniela ^b   Zotti, Carla Maria ^c   Martinese, Morena ^c   Bonanni, Paolo ^d   Boccalini, Sara ^e   Coppola, Rosa Cristina ^e   Masia, Giuseppina ^e   Meloni, Angelo ^e   Castiglia, Paolo ^f   Piana, Andrea ^f   Gasparini, Roberto ^b   Tanzi, Elisabetta ^a,b  

^a UNIVERSITY OF MILAN   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

^c UNIVERSITY OF TURIN   (Italy)

^d UNIVERSITY OF FLORENCE   (Italy)

^e UNIVERSITY OF CAGLIARI   (Italy)

^f UNIVERSITY OF SASSARI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ARTICLE; CHILD; CONTROLLED STUDY; DNA EXTRACTION; FEMALE; GENOTYPE; HUMAN; HUMAN PAPILLOMAVIRUS DNA TEST; ITALY; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PAPILLOMAVIRUS INFECTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SCHOOL CHILD; URINALYSIS; VIRUS DETECTION;

ADOLESCENT; CHILD; DNA, VIRAL; FEMALE; GENOTYPING TECHNIQUES; HUMANS; ITALY; MALE; PAPILLOMAVIRIDAE; VACCINATION;

EID: 84892548725     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0079719     Document Type: Article

References (36)

1. International Agency for Research on Cancer [IARC] (2011) Human Papillomaviruses. IARC Monogr Eval Carcinog Risks Hum 100B: 261-319. Available: http://monographs.iarc.fr/ENG/Monographs/vol100B/mono100B-1.pdf. Accessed 20 September 2013.
2. Centre for Diseases Control and Prevention [CDC] (2010) HPV vaccination. Available: http://www.cdc.gov/vaccines/vpd-vac/hpv/default.htm. Accessed 20 September 2013.
3. Collins S, Mazloomzadeh S, Winter H, Blomfield P, Bailey A et al. (2002) High incidence of human papillomavirus infection in women during their first sexual relationship. Br J Obstet Gynaecol 109: 96-98. doi:10.1111/j.1471-0528. 2002.01053.x.
4. Leval A, Sundström K, Ploner A, Dahlström LA, Widmark C et al. (2011) Assessing perceived risk and STI prevention behaviour: a national population-based study with special reference to HPV. PLOS ONE 6: e20624. Available: http://www.plosone.org/article/info:doi/10.1371/journal.pone.0020624. Accessed 20 September 2013. doi: 10.1371/journal.pone.0020624. PubMed: 21674050.
5. Brown DR, Shew ML, Qadadri B, Neptune N, Vargas M et al. (2007) A longitudinal study of genital human papillomavirus infection in a cohort of closely followed adolescent women. J Infect Dis 191: 182-192.
6. Moscicki AB (2007) HPV infections in adolescents. Dis Markers 23: 229-234. doi:10.1155/2007/136906. PubMed: 17627058.
7. Schiller JT, Castellsagué X, Garland SM (2012) A review of clinical trials of human papillomavirus prophylactic vaccines. Vaccine 30 (Suppl 5): F123-F138. doi:10.1016/j.vaccine.2012.04.108. PubMed: 23199956.
8. Food U.S. and Drug Administration [FDA] (2006) Centre for Biologics and Evaluation and Research, Office of Vaccines and Related Product Applications. Available: http://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ ucm111283.htm. Accessed 20 September 2013
9. Food U.S. and Drug Administration [FDA] (2009) Centre for Biologics and Evaluation and Research, Office of Vaccines and Related Product Applications. Available: http://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ ucm186959.htm. Accessed 20 September 2013
10. Gazzetta Ufficiale (2007) epubblica Italiana Serie Generale - N. 52. Available: http://www.gazzettaufficiale.it/atto/serie-generale/ caricaDettaglioAtto/originario? atto.dataPubblicazioneGazzetta=2007-03- 03&atto.codiceRedazionale=07A02016&elenco30giorni=.
11. Gazzetta Ufficiale (2007) epubblica Italiana Serie Generale - N. 271. Available: http://www.gazzettaufficiale.it/atto/serie-generale/ caricaDettaglioAtto/originario? atto.dataPubblicazioneGazzetta=2007-11- 21&atto.codiceRedazionale=07A09390&elenco30giorni=false. Accessed 20 September 2013.
12. Italian Minister of Health (2007) HPV vaccination in Italy. Available: http://www.ministerosalute.it/imgs/C-17-pubblicazioni-600-allegato.pdf. Accessed 20 September 2013.
13. Italian Minister of Health (2009) HPV vaccination coverage 95%. Available: http://www.statoregioni.it/Documenti/DOC-016696-264%20csr.pdf. Accessed 20 September 2013.
14. Crochard A, Luyts D, di Nicola S, Gonçalves MA (2009) Self-reported sexual debut and behaviour in young adults aged 18-24 years in seven European countries: implications for HPV vaccination programs. Gynecol Oncol 115: S7-S14. doi:10.1016/j.ygyno.2009.06.003. PubMed: 19552945.
15. Panatto D, Amicizia D, Lugarini J, Sasso T, Sormani MP et al. (2009) Sexual behaviour in Ligurian (Northern Italy) adolescents and young people: suggestions for HPV vaccination policies. Vaccine 27: A6-A10. doi:10.1016/j.vaccine.2009.06.009. PubMed: 19480964.
16. Panatto D, Amicizia D, Trucchi C, Casabona F, Lai PL et al. (2012) Sexual behaviour and risk factors for the acquisition of human papillomavirus infections in young people in Italy: suggestions for future vaccination policies. BMC Public Health 12: 623. doi: 10.1186/1471-2458-12-623. PubMed: 22871132.
17. Widdice L, Brown D, Bernstein D, Ding L, Patel D et al. (2011) Prevalence of HPV in sexually experienced and inexperienced females initiating HPV vaccination. J Adolesc Health 42: S2.
18. Shew ML, Weaver B, Tu W, Tong Y, Fortenberry JD et al. (2013) High frequency of Human Papillomavirus detection in the vagina before first vaginal intercourse among females enrolled in a longitudinal cohort study. J Infect Dis 207: 1012-1015. doi:10.1093/infdis/jis775. PubMed: 23242538.
19. Winer RL, Hughes JP, Feng Q, Xi LF, Cherne S et al. (2010) Detection of genital HPV types in fingertip samples from newly sexually active female university students. Cancer Epidemiol Biomarkers Prev 19: 1682-1685. doi:10.1158/1055-9965.EPI-10-0226. PubMed: 20570905.
20. Mollers M, Scherpenisse M, van der Klis FRM, King AJ, van Rossum TGJ et al. (2012) Prevalence of genital HPV infections and HPV serology in adolescent girls, prior to vaccination. Cancer Epidemiol 36: 519-524. doi:10.1016/j.canep. 2012.07.006. PubMed: 22906483.
21. Food U.S. and Drug Administration (2010) Centre for Biologics and Evaluation and Research, Office of Vaccines and Related Product Applications. Available: http://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ ucm094042.htm. Accessed 20 September 2013.
22. European Centre for Disease Control and Prevention [ECDC] (2012) Introduction of HPV vaccines in European Union countries an update. Available: http://ecdc.europa.eu/en/press/news/Lists/News/ECDC-DispForm.aspx?List= 32e43ee8-e230-4424-a783-85742124029a&ID=717. Accessed 20 September 2013
23. American Academy of Paediatrics [AAP] (2012) HPV Vaccine Recommendations. Committee on Infectious Diseases. Paediatrics. Available: http://www. pediatrics.org/cgi/doi/10.1542/peds.2011-3865. Accessed 20 September 2013
24. Tanzi E, Bianchi S, Fasolo MM, Frati ER, Mazza F et al. (2013) High performance of a new PCR-based urine assay for HPV-DNA detection and genotyping. J Med Virol 85: 91-98. doi:10.1002/jmv.23434. PubMed: 23097252.
25. Norbe RG, de Almeida LP, Martins TC (2008) Complete genotyping of mucosal human papilloma virus using a restriction fragment length polymorphism analysis and an original typing alghoritm. J Clin Virol 42: 13-21. doi:10.1016/j.jcv. 2007.11.021. PubMed: 18304866.
26. Open Source Epidemiologic Statistics for Public Health. Available: http://www.openepi.com. Accessed 20 September 2013
27. Agarossi A, Ferrazzi E, Parazzini F, Perno CF, Ghisoni L (2009) Prevalence and type distribution of high-risk human papillomavirus infection in women undergoing voluntary cervical cancer screening in Italy. J Med Virol 81: 529-535. doi:10.1002/jmv.21347. PubMed: 19152401.
28. Enerly E, Olofsson C, Nygård M (2013) Monitoring Human Papillomavirus prevalence in urine samples: a review. J Clin Epidemiol 5: 67-79. PubMed: 23516174.
29. O'Leary MC, Sinka K, Robertson C, Cuschieri K, Lyman R et al. (2011) HPV type-specific prevalence using a urine assay in unvaccinated male and female 11- to 18-year olds in Scotland. Br J Cancer 104: 1221-1226. doi:10.1038/bjc.2011. 30. PubMed: 21343934.
30. Hussain S, Bharadwaj M, Nasare V, Kumari M, Sharma S et al. (2012) Human Papillomavirus infection among young adolescents in India: impact of vaccination. J Med Virol 84: 298-305. doi:10.1002/jmv.22261. PubMed: 22170551.
31. Piana A, Sotgiu G, Castiglia P, Pischedda S, Cocuzza C et al. (2011) Prevalence and type distribution of human papillomavirus infection in women from North Sardinia, Italy. BMC Public Health 11: 785. doi: 10.1186/1471-2458-11- 785. PubMed: 21989375.
32. Alameda F, Bellosillo B, Fusté P, Musset M, Mariñoso ML et al. (2007) Human papillomavirus detection in urine samples: an alternative screening method. J Low Genit Tract Dis 11: 5-7. doi:10.1097/01.lgt. 0000230204.65742.e4. PubMed: 17194943.
33. Sehgal A, Gupta S, Parashari A, Sodhani P, Singh V (2009) Urine HPV-DNA detection for cervical cancer screening: Prospects and prejudices. J Obstet Gynaecol 29: 583-589. doi: 10.1080/01443610903061736. PubMed: 19757259.
34. Partridge JM, Hughes JP, Feng Q, Winer RL, Weaver BA et al. (2007) Genital human Papillomavirus infection in men: incidence and risk factors in a cohort of university students. J Infect Dis 196: 1128-1136. doi:10.1086/521192. PubMed: 17955430.
35. Giuliano AR, Nielson CM, Flores R, Dunne EF, Abrahamsen M et al. (2007) The optimal anatomic sites for sampling heterosexual men for human papillomavirus (HPV) detection: the HPV detection in men study. J Infect Dis 196: 1146-1152. doi:10.1086/521629. PubMed: 17955432.
36. Gasparini R, Amicizia D, Manfredi P, Ansaldi F, Lucioni C et al. (2009) Human papillomavirus vaccination: what is the best choice? A comparison of 16 strategies by means of a decisional model. Epidemiol Infect 137: 794-802. doi:10.1017/S0950268808001441. PubMed: 18925989.